Project Grant CE154323

Award Date 9/30/24
Completion Date 9/29/27
Dollars Obligated $30M
Funding Federal Agency
Healthcare Systems Bureau
Federal Grant Program
93.493
Assistance Type
Project Grant
Place of Performance
Kansas City, KS, USA
Similar Awards
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) received a $27,720,000 Project Grant award from the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects (CFDA 11.617) program. The funding will support construction of a 33,000 square foot research wing for the University of Kansas Cancer Center, which recently earned the prestigious NCI Comprehensive Cancer Center designation. The new facility will house basic science,...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $8,000,000 Project Grant on September 8, 2023 from the National Institutes of Health (NIH) Construction Support program (CFDA 93.352) to renovate and construct a new multi-modality pre-clinical imaging facility as part of a broader campus-wide vivarium and cancer center expansion project. The facility will serve the research needs of the entire University of Kansas Medical Center campus, providing advanced...
This $620,000 Project Grant, awarded on June 15, 2024 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research by the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to elucidate the late effects of radiation in head and neck cancer patients. The research aims to advance scientific knowledge and develop innovative therapies in the field of cancer. As a prime federal grant recipient, KUMCRI has an extensive...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $172,197 to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to establish and refine processes that facilitate clinical trials in cancer interception (active cancer prevention) at the University of Kansas Cancer Center. The key products and services to be delivered under this 5-year grant include: hiring project navigators to facilitate study approvals...
The University of Kansas Hospital Authority, doing business as the University of Kansas Health System, was awarded a $40,000,000 Project Grant from the Department of Health and Human Services' Healthcare Systems Bureau under the Congressional Directives program (CFDA 93.493). The grant will fund the acquisition of advanced medical imaging equipment to enhance the organization's Alzheimer's disease diagnosis capabilities. This award, with a performance period from September 30, 2024 to...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $930,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on March 1, 2024, supports research to investigate the progression of ductal carcinoma in situ (DCIS) to invasive basal-like breast cancer, with a focus on the role of N-RAS. The research aims to advance scientific knowledge and develop innovative therapies in the...
The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) was awarded a $766,886.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on Sep 30, 2023. The 2-year grant supports research on the importance of NKG2D signaling-induced IL-24 secretion by tumor-specific CD8+ T cells. Through this biomedical research project, KUMCRI aims to investigate medical solutions that could transform health care for Service...
This $1,395,000 Project Grant award from the Department of Defense's Defense Health Agency was made to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) on April 1, 2024. The grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research related to military medicine, with a focus on areas such as cancer and neurological disorders. The purpose of this 3-year grant is to develop a short peptide-based...
The U.S. Department of Health and Human Services (HHS) Health Resources and Services Administration (HRSA) awarded a $2,850,000 Project Grant under the Congressional Directives program (CFDA 93.493) to Kansas Health Science University, Inc., a not-for-profit organization based in Wichita, Kansas. This 3-year grant, awarded on September 30, 2023, will support a community construction project in Wichita. The Congressional Directives program funds a range of special projects and programs identified...
This federal Project Grant award of $6,000,000.00 was issued on September 30, 2024 by the Department of Health and Human Services (HHS) under the Congressional Directives program (CFDA 93.493). The award supports a construction project at Kansas State University, a public land-grant research university in Manhattan, Kansas. The grant will fund the construction or renovation of healthcare facilities, equipment purchases, and implementation of specialized service programs to address critical...

The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) received a $30,000,000 Project Grant from the Health Resources and Services Administration (HRSA), under the Congressional Directives program (CFDA 93.493), to support the construction of a 205,000 square foot University of Kansas Cancer Center building. This centralized facility will house cancer researchers, clinicians, and population health experts, facilitating increased collaboration and enabling the expansion of research teams in basic science, clinical, and population health domains. The project aims to enhance access to leading-edge cancer treatments, including clinical trials, for the local community, with a focus on serving underserved and marginalized population groups. The grant award was provided on September 30, 2024, with a project completion date of September 29, 2027.

Generated 4/29/25, 1:42 AM